CAD-T2DM without MI/stroke population | THEMIS-like population | PCI THEMIS-like population | |
---|---|---|---|
n = 258,260 | n = 64,334 | n = 11,622 | |
Age in years, mean (± SD) | 72.7 (10.6) | 72.3 (10.2) | 70.9 (9.5) |
Gender male, n (%) | 176,407 (68.3) | 42,238 (65.7) | 8693 (74.8) |
Disease history, n (%) | |||
T2DM Long Term Disease registration | 199,425 (77.2) | 50,060 (77.8) | 9058 (77.9) |
CAD Long Term Disease registration | 111,419 (43.1) | 28,144 (43.7) | 6327 (54.4) |
T2DM history ≥ 5 years | 142,562 (55.2) | 35,432 (55.1) | 6386 (54.9) |
CAD history ≥ 5 years | 121,639 (47.1) | 29,562 (46.0) | 5264 (45.3) |
Both CAD and T2DM history ≥ 5 years | 67,040 (26.0) | 16,346 (25.4) | 3039 (26.1) |
PCI within the 5-year history | 71,576 (27.7) | 11 657 (18.1) | 11,622 (100) |
CABG within the 5-year history | 1860 (0.72) | 335 (0.5) | 0 |
Major comorbidities, n (%) | |||
Hypertension | 204,943 (79.4) | 48,554 (75.5) | 8954 (77.0) |
Atrial fibrillation | 55,155 (21.4) | 6647 (10.3) | 992 (8.5) |
Renal impairment | 51,647 (20.0) | 2943 (4.6) | 429 (3.7) |
Peripheral arterial disease | 49,703 (19.2) | 7326 (11.4) | 1462 (12.6) |
Dyslipidemia | 49,406 (19.1) | 10,673 (16.6) | 2564 (22.1) |
Cancer | 47,066 (18.2) | 10,958 (17.0) | 1788 (15.4) |
Heart failure | 41,744 (16.2) | 5821 (9.0) | 932 (8.0) |
Chronic obstructive pulmonary disease | 35,558 (13.8) | 7137 (11.1) | 1092 (9.4) |
Obstructive sleep apnea syndrome, n (%) | 58,497 (22.7) | 13,090 (20.3) | 822 (7.1) |
Diabetic complications, n (%) | 101,419 (39.3) | 20,301 (31.6) | 3908 (33.6) |
Diabetic foot ulcer | 68,149 (26.4) | 13,506 (21.0) | 3077 (26,5) |
Diabetic nephropathy | 33,126 (12.8) | 4299 (6.7) | 645 (5.5) |
Diabetic retinopathy | 27,715 (10.7) | 5400 (8.4) | 776 (6.7) |
Diabetic neuropathy | 25,891 (10.0) | 4874 (7.6) | 667 (5.7) |